150 — Palo Alto, California

150 is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

150 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Sponsors: Corcept Therapeutics.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 150?

150 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 150 conducted?

150 has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Is 150 accredited by Crixeo Health?

150 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 150?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.